Trial Profile
Anti-fibrotic activity of Irbesartan in chronic hepatitis with hypertension using Elastography.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 25 Feb 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Nov 2009 New trial record